|
Name |
Chaetoviridin A
|
Molecular Formula | C23H25ClO6 | |
IUPAC Name* |
(6aS)-5-chloro-9-[(2S,3R)-3-hydroxy-2-methylbutanoyl]-6a-methyl-3-[(E,3S)-3-methylpent-1-enyl]furo[2,3-h]isochromene-6,8-dione
|
|
SMILES |
CC[C@H](C)/C=C/C1=CC2=C(C(=O)[C@@]3(C(=C(C(=O)O3)C(=O)[C@@H](C)[C@@H](C)O)C2=CO1)C)Cl
|
|
InChI |
InChI=1S/C23H25ClO6/c1-6-11(2)7-8-14-9-15-16(10-29-14)18-17(20(26)12(3)13(4)25)22(28)30-23(18,5)21(27)19(15)24/h7-13,25H,6H2,1-5H3/b8-7+/t11-,12-,13+,23-/m0/s1
|
|
InChIKey |
HWSQVPGTQUYLEQ-CCBHEJLASA-N
|
|
Synonyms |
Chaetoviridin A; 128252-98-2; CCRIS 7226; (6aS)-5-chloro-9-[(2S,3R)-3-hydroxy-2-methylbutanoyl]-6a-methyl-3-[(E,3S)-3-methylpent-1-enyl]furo[2,3-h]isochromene-6,8-dione; CHEBI:67610; CHEMBL1802150; DTXSID80893270; (6aS)-5-chloro-9-[(2S,3R)-3-hydroxy-2-methylbutanoyl]-6a-methyl-3-[(1E,3S)-3-methylpent-1-en-1-yl]-6H-furo[2,3-h]isochromene-6,8(6aH)-dione; HB3829; 1267888-95-8; J-005582; Q27136080; (6aS)-5-chloro-9-[(2S,3R)-3-hydroxy-2-methyl-butanoyl]-6a-methyl-3-[(E,3S)-3-methylpent-1-enyl]furo[2,3-h]isochromene-6,8-dione; 6H-Furo[2,3-h]-2-benzopyran-6,8(6aH)-dione, 5-chloro-9-[(2S,3R)-3-hydroxy-20methyl-1-oxobutyl]-6a-methyl-3-[(1E,3S)-3-methyl-1-pentenyl)-,(6aS)
|
|
CAS | 1308671-17-1 | |
PubChem CID | 6450533 | |
ChEMBL ID | CHEMBL1802150 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 432.9 | ALogp: | 3.3 |
HBD: | 1 | HBA: | 6 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 89.9 | Aromatic Rings: | 3 |
Heavy Atoms: | 30 | QED Weighted: | 0.495 |
Caco-2 Permeability: | -4.76 | MDCK Permeability: | 0.00001930 |
Pgp-inhibitor: | 0.361 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.056 | 20% Bioavailability (F20%): | 0.906 |
30% Bioavailability (F30%): | 0.9 |
Blood-Brain-Barrier Penetration (BBB): | 0.186 | Plasma Protein Binding (PPB): | 80.52% |
Volume Distribution (VD): | 2.269 | Fu: | 9.47% |
CYP1A2-inhibitor: | 0.952 | CYP1A2-substrate: | 0.688 |
CYP2C19-inhibitor: | 0.935 | CYP2C19-substrate: | 0.571 |
CYP2C9-inhibitor: | 0.914 | CYP2C9-substrate: | 0.037 |
CYP2D6-inhibitor: | 0.94 | CYP2D6-substrate: | 0.013 |
CYP3A4-inhibitor: | 0.961 | CYP3A4-substrate: | 0.302 |
Clearance (CL): | 2.065 | Half-life (T1/2): | 0.156 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.941 |
Drug-inuced Liver Injury (DILI): | 0.981 | AMES Toxicity: | 0.483 |
Rat Oral Acute Toxicity: | 0.771 | Maximum Recommended Daily Dose: | 0.889 |
Skin Sensitization: | 0.921 | Carcinogencity: | 0.931 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.012 |
Respiratory Toxicity: | 0.951 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002525 | 0.736 | D0WY9N | 0.217 | ||||
ENC002010 | 0.663 | D03KIA | 0.216 | ||||
ENC005878 | 0.571 | D0JE2E | 0.209 | ||||
ENC005844 | 0.571 | D0C1SF | 0.208 | ||||
ENC005420 | 0.537 | D0O6KE | 0.208 | ||||
ENC004761 | 0.537 | D02GAC | 0.194 | ||||
ENC003626 | 0.500 | D0R6RC | 0.194 | ||||
ENC002613 | 0.491 | D0Z1WA | 0.191 | ||||
ENC004762 | 0.487 | D0QD1G | 0.188 | ||||
ENC002529 | 0.486 | D0TK7R | 0.187 |